
Nearly half of all women report symptoms of chemotherapy-induced peripheral neuropathy (CIPN) long after their cancer treatment has ended, and those with the condition have a significantly higher risk of falls, altered walking patterns, and other difficulties in physical functioning, a new study has found.






























